-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Generally speaking, the impression that marijuana gives to people is to make people happy! This impression makes us feel inexplicable about the legalization of cannabis in European and American countries in the past two years.
Generally speaking, the impression that marijuana gives to people is to make people happy! This impression makes us feel inexplicable about the legalization of cannabis in European and American countries in the past two years.
This is a double-blind, randomized, placebo-controlled, single-center trial.
The study included 56 patients, approximately 34.
Figure: Hemp's relief of disease histology
This study confirmed that patients with Crohn's disease receiving eight weeks of CBD-rich cannabis treatment can induce clinical remission of the disease and greatly improve the patient's quality of life, while there is no significant change in inflammation parameters or endoscopic scores.
This study confirmed that patients with Crohn's disease receiving eight weeks of CBD-rich cannabis treatment can induce clinical remission of the disease and greatly improve the patient's quality of life, while there is no significant change in inflammation parameters or endoscopic scores.
Original source:
Timna Naftali.
oup.
com/ecco-jcc/advance-article-abstract/doi/10.
1093/ecco-jcc/jjab069/6226910?redirectedFrom=fulltext" target="_blank" rel="noopener">Oral CBD-rich cannabis induces clinical but not endoscopic response in patients with Crohn's disease, a randomized controlled trial.
Leave a message here
